These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1005 related items for PubMed ID: 28231544

  • 1. Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer.
    Yuan Z, Jiang H, Zhu X, Liu X, Li J.
    Biomed Pharmacother; 2017 May; 89():227-232. PubMed ID: 28231544
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel.
    Kim SM, Lee SY, Yuk DY, Moon DC, Choi SS, Kim Y, Han SB, Oh KW, Hong JT.
    Arch Pharm Res; 2009 May; 32(5):755-65. PubMed ID: 19471891
    [Abstract] [Full Text] [Related]

  • 3. Ginsenoside Rg3 inhibits colorectal tumor growth via down-regulation of C/EBPβ/NF-κB signaling.
    Yang X, Zou J, Cai H, Huang X, Yang X, Guo D, Cao Y.
    Biomed Pharmacother; 2017 Dec; 96():1240-1245. PubMed ID: 29169725
    [Abstract] [Full Text] [Related]

  • 4. Protective effects of ginsenoside Rg3 on TNF-α-induced human nucleus pulposus cells through inhibiting NF-κB signaling pathway.
    Chen J, Liu GZ, Sun Q, Zhang F, Liu CY, Yuan L, Zhao XQ, Wang YJ, Jia YS.
    Life Sci; 2019 Jan 01; 216():1-9. PubMed ID: 30428306
    [Abstract] [Full Text] [Related]

  • 5. Ginsenoside Rg3 induces apoptosis in human multiple myeloma cells via the activation of Bcl-2-associated X protein.
    Luo Y, Zhang P, Zeng HQ, Lou SF, Wang DX.
    Mol Med Rep; 2015 Sep 01; 12(3):3557-3562. PubMed ID: 25998024
    [Abstract] [Full Text] [Related]

  • 6. Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB.
    Kim SM, Lee SY, Cho JS, Son SM, Choi SS, Yun YP, Yoo HS, Yoon DY, Oh KW, Han SB, Hong JT.
    Eur J Pharmacol; 2010 Apr 10; 631(1-3):1-9. PubMed ID: 20056115
    [Abstract] [Full Text] [Related]

  • 7. Carbon nanotubes (CNT)-loaded ginsenosides Rb3 suppresses the PD-1/PD-L1 pathway in triple-negative breast cancer.
    Luo X, Wang H, Ji D.
    Aging (Albany NY); 2021 Jun 10; 13(13):17177-17189. PubMed ID: 34111025
    [Abstract] [Full Text] [Related]

  • 8. Ginsenoside Rg3 suppresses FUT4 expression through inhibiting NF-κB/p65 signaling pathway to promote melanoma cell death.
    Shan X, Tian LL, Zhang YM, Wang XQ, Yan Q, Liu JW.
    Int J Oncol; 2015 Aug 10; 47(2):701-9. PubMed ID: 26094873
    [Abstract] [Full Text] [Related]

  • 9. Boswellia ovalifoliolata abrogates ROS mediated NF-κB activation, causes apoptosis and chemosensitization in Triple Negative Breast Cancer cells.
    Thummuri D, Jeengar MK, Shrivastava S, Areti A, Yerra VG, Yamjala S, Komirishetty P, Naidu VG, Kumar A, Sistla R.
    Environ Toxicol Pharmacol; 2014 Jul 10; 38(1):58-70. PubMed ID: 24908637
    [Abstract] [Full Text] [Related]

  • 10. Ginsenoside Rk1 induces cell cycle arrest and apoptosis in MDA-MB-231 triple negative breast cancer cells.
    Hong Y, Fan D.
    Toxicology; 2019 Apr 15; 418():22-31. PubMed ID: 30797898
    [Abstract] [Full Text] [Related]

  • 11. Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells.
    Zhang C, Liu L, Yu Y, Chen B, Tang C, Li X.
    Mol Med Rep; 2012 May 15; 5(5):1295-8. PubMed ID: 22366885
    [Abstract] [Full Text] [Related]

  • 12. Ginsenoside Rg3 sensitizes human non-small cell lung cancer cells to γ-radiation by targeting the nuclear factor-κB pathway.
    Wang L, Li X, Song YM, Wang B, Zhang FR, Yang R, Wang HQ, Zhang GJ.
    Mol Med Rep; 2015 Jul 15; 12(1):609-14. PubMed ID: 25738799
    [Abstract] [Full Text] [Related]

  • 13. Ginsenoside Rg3 attenuates endometriosis by inhibiting the viability of human ectopic endometrial stromal cells through the nuclear factor-kappaB signaling pathway.
    Huang R, Chen S, Zhao M, Li Z, Zhu L.
    J Gynecol Obstet Hum Reprod; 2020 Jan 15; 49(1):101642. PubMed ID: 31563698
    [Abstract] [Full Text] [Related]

  • 14. Ginsenoside Rg3 Suppresses Proliferation and Induces Apoptosis in Human Osteosarcoma.
    Li Y, Lu J, Bai F, Xiao Y, Guo Y, Dong Z.
    Biomed Res Int; 2018 Jan 15; 2018():4306579. PubMed ID: 29750154
    [Abstract] [Full Text] [Related]

  • 15. CKD712, a synthetic isoquinoline alkaloid, enhances the anti-cancer effects of paclitaxel in MDA-MB-231 cells through regulation of PTEN.
    Kim YM, Tsoyi K, Jang HJ, Park EJ, Park SW, Kim HJ, Hwa JS, Chang KC.
    Life Sci; 2014 Sep 01; 112(1-2):49-58. PubMed ID: 25058922
    [Abstract] [Full Text] [Related]

  • 16. Ginsenoside Ro suppresses interleukin-1β-induced apoptosis and inflammation in rat chondrocytes by inhibiting NF-κB.
    Zhang XH, Xu XX, Xu T.
    Chin J Nat Med; 2015 Apr 01; 13(4):283-9. PubMed ID: 25908625
    [Abstract] [Full Text] [Related]

  • 17. [Effect of ginsenoside Rg3 on Pim-3 and Bad proteins in human pancreatic cancer cell line PANC-1].
    Jian J, Hu ZF, Huang Y.
    Ai Zheng; 2009 May 01; 28(5):461-5. PubMed ID: 19624871
    [Abstract] [Full Text] [Related]

  • 18. Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway.
    Peng B, He R, Xu Q, Yang Y, Hu Q, Hou H, Liu X, Li J.
    Pharmacol Res; 2019 Apr 01; 142():1-13. PubMed ID: 30735802
    [Abstract] [Full Text] [Related]

  • 19. Panepoxydone targets NF-kB and FOXM1 to inhibit proliferation, induce apoptosis and reverse epithelial to mesenchymal transition in breast cancer.
    Arora R, Yates C, Gary BD, McClellan S, Tan M, Xi Y, Reed E, Piazza GA, Owen LB, Dean-Colomb W.
    PLoS One; 2014 Apr 01; 9(6):e98370. PubMed ID: 24896091
    [Abstract] [Full Text] [Related]

  • 20. [Inducement effect of ginsenoside Rg3 on apoptosis of human bladder transitional cell carcinoma cell line EJ].
    Chen JX, Peng HM, Pu SP, Guo YP.
    Zhongguo Zhong Yao Za Zhi; 2007 Aug 01; 32(16):1680-4. PubMed ID: 18027667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.